Granata Bio Acquires Oviva Therapeutics

Gedeon Richter Acquires Significant Stake in Granata Bio

May 13, 2025

Biotechnology

Gedeon Richter Plc. has acquired a significant equity stake in U.S.-based Granata Bio and will appoint a representative to Granata's board. The companies also signed a binding term sheet to co-develop BEMFOLA for the U.S. market and a royalty purchase agreement for Granata's hMG program, strengthening Richter's U.S. presence and Granata's fertility therapeutics portfolio.

Labcorp Acquires Ovia Health

August 12, 2021

Healthcare Services

Labcorp acquired Ovia Health, a digital women's health platform that supports family planning, pregnancy and parenting, to expand its women's health capabilities and digital offerings. The acquisition builds on a prior strategic investment from Labcorp's Venture Fund and aims to combine Labcorp's diagnostics and genetics expertise with Ovia's digital platform to improve patient experience and outcomes; terms were not disclosed.

Vividion Therapeutics Acquires Tavros Therapeutics

January 12, 2025

Biotechnology

Vividion Therapeutics, a wholly owned subsidiary of Bayer AG, has acquired precision oncology platform company Tavros Therapeutics. The acquisition expands Vividion’s functional genomics and genomic screening capabilities, combining Tavros’s platform with Vividion’s chemoproteomics expertise to accelerate discovery of novel targets in oncology and immunology; financial terms were not disclosed.

Ivy Fertility Acquires NOVA IVF

May 31, 2023

Healthcare Services

Ivy Fertility has acquired NOVA IVF, a Mountain View, California-based fertility and IVF practice led by Drs. Richard Schmidt and Meera Shah. The acquisition expands Ivy Fertility's network and clinical capacity in the San Francisco Bay Area, adding to its multi-state reproductive medicine platform.

In Vitro Sciences (Sverica) Partners with InVia Fertility Specialists

August 26, 2020

Healthcare Services

In Via Fertility Specialists has entered a partnership with In Vitro Sciences, a portfolio company of Sverica Capital Management, with Dresner Partners advising InVia on the transaction. InVia — a four-location fertility clinic group in the Chicagoland area with an on-site embryology lab and three reproductive endocrinologists — will gain strategic, operational and financial resources to support growth and enhance patient care.

Veos Group Acquires OvaInnovations' U.S. Operations

November 6, 2024

Food & Beverage

Veos Group has acquired the activities/operations of OvaInnovations, a producer of inedible egg proteins, giving Veos production capabilities in the United States. The deal expands Veos Group’s global footprint and strengthens its ACTIPRO portfolio for food, feed and pet food customers.